{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,15]],"date-time":"2026-01-15T16:44:05Z","timestamp":1768495445737,"version":"3.49.0"},"reference-count":31,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100015640","name":"Huazhong University of Science and Technology Tongji Medical College Tongji Hospital","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100015640","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003399","name":"Science and Technology Commission of Shanghai Municipality","doi-asserted-by":"publisher","award":["21Y11908800"],"award-info":[{"award-number":["21Y11908800"]}],"id":[{"id":"10.13039\/501100003399","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004204","name":"Tongji University","doi-asserted-by":"publisher","award":["ZD) 2206 ]"],"award-info":[{"award-number":["ZD) 2206 ]"]}],"id":[{"id":"10.13039\/501100004204","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Transplant Immunology"],"published-print":{"date-parts":[[2025,12]]},"DOI":"10.1016\/j.trim.2025.102321","type":"journal-article","created":{"date-parts":[[2025,10,28]],"date-time":"2025-10-28T17:37:32Z","timestamp":1761673052000},"page":"102321","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Subtype-specific progression of post-transplant lymphoproliferative disease (PTLD) in children: Implications for age-based surveillance and early intervention strategies"],"prefix":"10.1016","volume":"93","author":[{"given":"Sujie","family":"Wang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhipeng","family":"Zong","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Li","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yu","family":"Zeng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jianchen","family":"Fang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.trim.2025.102321_bb0005","article-title":"Post-transplantation lymphoproliferative disorder (PTLD): in the liver transplant recipient","author":"Janeela","year":"2023","journal-title":"J. Clin. Exp. Hepatol."},{"issue":"8","key":"10.1016\/j.trim.2025.102321_bb0010","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1007\/s11912-023-01418-0","article-title":"Important considerations in the diagnosis and management of post-transplant lymphoproliferative disorder","volume":"25","author":"Lee","year":"2023","journal-title":"Curr. Oncol. Rep."},{"issue":"8","key":"10.1016\/j.trim.2025.102321_bb0015","doi-asserted-by":"crossref","first-page":"1165","DOI":"10.1002\/lt.26034","article-title":"Post-transplant lymphoproliferative disorders after liver transplantation: a retrospective cohort study including 1954 transplants","volume":"27","author":"Tajima","year":"2021","journal-title":"Liver Transpl."},{"issue":"5","key":"10.1016\/j.trim.2025.102321_bb0020","doi-asserted-by":"crossref","first-page":"881","DOI":"10.1093\/ndt\/gfx356","article-title":"Incidence and predictors of post-transplant lymphoproliferative disease after kidney transplantation during adulthood and childhood: a registry study","volume":"33","author":"Francis","year":"2018","journal-title":"Nephrol. Dial. Transplant."},{"issue":"10","key":"10.1016\/j.trim.2025.102321_bb0025","doi-asserted-by":"crossref","DOI":"10.1097\/HS9.0000000000000640","article-title":"Clinicopathologic characteristics, treatment, and outcomes of post-transplant lymphoproliferative disorders: a single-institution experience using 2017 WHO diagnostic criteria","volume":"5","author":"King","year":"2021","journal-title":"Hemasphere"},{"issue":"17","key":"10.1016\/j.trim.2025.102321_bb0030","doi-asserted-by":"crossref","first-page":"1426","DOI":"10.1182\/blood.2023020075","article-title":"How I treat posttransplant lymphoproliferative disorder","volume":"142","author":"Amengual","year":"2023","journal-title":"Blood"},{"issue":"4","key":"10.1016\/j.trim.2025.102321_bb0035","doi-asserted-by":"crossref","DOI":"10.3390\/cancers13040899","article-title":"Analysis of post-transplant lymphoproliferative disorder (PTLD) outcomes with Epstein-Barr virus (EBV) assessments-a single tertiary referral center experience and review of literature","volume":"13","author":"Lau","year":"2021","journal-title":"Cancers (Basel)"},{"issue":"3","key":"10.1016\/j.trim.2025.102321_bb0040","doi-asserted-by":"crossref","first-page":"976","DOI":"10.3390\/cancers15030976","article-title":"Relationship of post-transplant lymphoproliferative disorders (PTLD) subtypes and clinical outcome in pediatric heart transplant recipients: a retrospective single institutional analysis\/experience of 558 patients","volume":"15","author":"Liu","year":"2023","journal-title":"Cancers"},{"key":"10.1016\/j.trim.2025.102321_bb0045","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s40164-017-0087-0","article-title":"Post-transplant lymphoproliferative disorder (PTLD): single institutional experience of 141 patients","volume":"6","author":"Bishnoi","year":"2017","journal-title":"Exp. Hematol. Oncol."},{"issue":"5","key":"10.1016\/j.trim.2025.102321_bb0050","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1182\/blood.2022019543","article-title":"Decoding the molecular heterogeneity of pediatric monomorphic post-solid organ transplant lymphoproliferative disorders","volume":"142","author":"Salmer\u00f3n-Villalobos","year":"2023","journal-title":"Blood"},{"issue":"1","key":"10.1016\/j.trim.2025.102321_bb0055","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/j.canlet.2015.08.007","article-title":"Post-transplant lymphoproliferative disorders: from epidemiology to pathogenesis-driven treatment","volume":"369","author":"Petrara","year":"2015","journal-title":"Cancer Lett."},{"issue":"8","key":"10.1016\/j.trim.2025.102321_bb0060","doi-asserted-by":"crossref","DOI":"10.1111\/ctr.13313","article-title":"Clinical characteristics and outcomes of PTLD following intestinal transplantation","volume":"32","author":"Wozniak","year":"2018","journal-title":"Clin. Transpl."},{"key":"10.1016\/j.trim.2025.102321_bb0065","doi-asserted-by":"crossref","first-page":"506","DOI":"10.3389\/fonc.2020.00506","article-title":"Biological difference between Epstein-Barr virus positive and negative post-transplant lymphoproliferative disorders and their clinical impact","volume":"10","author":"Ferla","year":"2020","journal-title":"Front. Oncol."},{"issue":"1","key":"10.1016\/j.trim.2025.102321_bb0070","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1097\/TP.0b013e318277e344","article-title":"Characteristics of early and late PTLD development in pediatric solid organ transplant recipients","volume":"95","author":"Schober","year":"2013","journal-title":"Transplantation"},{"issue":"2","key":"10.1016\/j.trim.2025.102321_bb0075","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1111\/bjh.19255","article-title":"Epstein-Barr virus-associated lymphomas decoded","volume":"204","author":"Bednarska","year":"2024","journal-title":"Br. J. Haematol."},{"key":"10.1016\/j.trim.2025.102321_bb0080","article-title":"Post-transplant lymphoproliferative disorders following kidney transplantation: a literature review with updates on risk factors, prognostic indices, screening strategies, treatment and analysis of donor type","volume":"100837","author":"Ergisi","year":"2024","journal-title":"Transplant. Rev."},{"issue":"1","key":"10.1016\/j.trim.2025.102321_bb0085","doi-asserted-by":"crossref","first-page":"728","DOI":"10.1182\/hematology.2024000583","article-title":"EBV and post-transplant lymphoproliferative disorder: a complex relationship","volume":"2024","author":"El-Mallawany","year":"2024","journal-title":"Hematology Am. Soc. Hematol. Educ. Program"},{"issue":"1","key":"10.1016\/j.trim.2025.102321_bb0090","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.hbpd.2019.12.005","article-title":"Impact of EBV infection and immune function assay for lymphoproliferative disorder in pediatric patients after liver transplantation: a single-center experience","volume":"19","author":"Qin","year":"2020","journal-title":"Hepatobiliary Pancreat. Dis. Int."},{"issue":"6","key":"10.1016\/j.trim.2025.102321_bb0095","doi-asserted-by":"crossref","DOI":"10.1002\/jmv.29767","article-title":"Post-transplant lymphoproliferative disorder associated Epstein-Barr virus DNAemia after liver transplantation in children: experience from single center","volume":"96","author":"Dogan","year":"2024","journal-title":"J. Med. Virol."},{"issue":"8","key":"10.1016\/j.trim.2025.102321_bb0100","doi-asserted-by":"crossref","DOI":"10.3390\/jcm11082166","article-title":"Management of Epstein-Barr Virus Infection and Post-Transplant Lymphoproliferative Disorder in pediatric liver transplantation","volume":"11","author":"Okamoto","year":"2022","journal-title":"J. Clin. Med."},{"issue":"2","key":"10.1016\/j.trim.2025.102321_bb0105","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1053\/j.ajkd.2021.01.015","article-title":"Posttransplant lymphoproliferative disorder following kidney transplantation: a review","volume":"78","author":"Sprangers","year":"2021","journal-title":"Am. J. Kidney Dis."},{"issue":"9","key":"10.1016\/j.trim.2025.102321_bb0110","doi-asserted-by":"crossref","first-page":"1362","DOI":"10.1016\/j.jfma.2018.12.007","article-title":"Roles of Epstein-Barr virus viral load monitoring in the prediction of posttransplant lymphoproliferative disorder in pediatric liver transplantation","volume":"118","author":"Chen","year":"2019","journal-title":"J. Formos. Med. Assoc."},{"issue":"12","key":"10.1016\/j.trim.2025.102321_bb0115","doi-asserted-by":"crossref","first-page":"3001","DOI":"10.1182\/bloodadvances.2023011626","article-title":"Tabelecleucel for EBV+ PTLD after allogeneic HCT or SOT in a multicenter expanded access protocol","volume":"8","author":"Nikiforow","year":"2024","journal-title":"Blood Adv."},{"key":"10.1016\/j.trim.2025.102321_bb0120","doi-asserted-by":"crossref","DOI":"10.3389\/fcimb.2022.980113","article-title":"Clinical value of plasma and peripheral blood mononuclear cells Epstein-Barr virus DNA dynamics on prognosis of allogeneic stem cell transplantation","volume":"12","author":"Zhou","year":"2022","journal-title":"Front. Cell. Infect. Microbiol."},{"issue":"16","key":"10.1016\/j.trim.2025.102321_bb0125","doi-asserted-by":"crossref","first-page":"2007","DOI":"10.1182\/blood-2015-09-672030","article-title":"The clinical significance of EBV DNA in the plasma and peripheral blood mononuclear cells of patients with or without EBV diseases","volume":"127","author":"Kanakry","year":"2016","journal-title":"Blood"},{"issue":"2","key":"10.1016\/j.trim.2025.102321_bb0130","doi-asserted-by":"crossref","DOI":"10.1016\/j.jceh.2023.09.007","article-title":"Post-transplantation lymphoproliferative disorder (PTLD): in the liver transplant recipient","volume":"14","author":"Janeela","year":"2024","journal-title":"J. Clin. Exp. Hepatol."},{"issue":"3","key":"10.1016\/j.trim.2025.102321_bb0135","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1111\/bjh.18498","article-title":"Burkitt lymphoma after solid-organ transplant: treatment and outcomes in the paediatric PTLD collaborative","volume":"200","author":"Afify","year":"2023","journal-title":"Br. J. Haematol."},{"issue":"5","key":"10.1016\/j.trim.2025.102321_bb0140","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1182\/blood.2023020768","article-title":"Evolving beyond morphology in pediatric PTLD","volume":"142","author":"El-Mallawany","year":"2023","journal-title":"Blood"},{"issue":"282","key":"10.1016\/j.trim.2025.102321_bb0145","article-title":"Evolution of the immune system in humans from infancy to old age","volume":"2015","author":"Simon","year":"1821","journal-title":"Proc. Biol. Sci."},{"issue":"4","key":"10.1016\/j.trim.2025.102321_bb0150","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1053\/j.sempedsurg.2017.07.002","article-title":"Post-transplant lymphoproliferative disorder after solid-organ transplant in children","volume":"26","author":"Absalon","year":"2017","journal-title":"Semin. Pediatr. Surg."},{"issue":"7","key":"10.1016\/j.trim.2025.102321_bb0155","doi-asserted-by":"crossref","first-page":"1224","DOI":"10.3748\/wjg.v23.i7.1224","article-title":"Post-transplant lymphoproliferative disorder after liver transplantation: incidence, long-term survival and impact of serum tacrolimus level","volume":"23","author":"Eshraghian","year":"2017","journal-title":"World J. Gastroenterol."}],"container-title":["Transplant Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0966327425001492?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0966327425001492?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,1,15]],"date-time":"2026-01-15T01:33:45Z","timestamp":1768440825000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0966327425001492"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12]]},"references-count":31,"alternative-id":["S0966327425001492"],"URL":"https:\/\/doi.org\/10.1016\/j.trim.2025.102321","relation":{},"ISSN":["0966-3274"],"issn-type":[{"value":"0966-3274","type":"print"}],"subject":[],"published":{"date-parts":[[2025,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Subtype-specific progression of post-transplant lymphoproliferative disease (PTLD) in children: Implications for age-based surveillance and early intervention strategies","name":"articletitle","label":"Article Title"},{"value":"Transplant Immunology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.trim.2025.102321","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"102321"}}